0001062993-15-002351.txt : 20150504 0001062993-15-002351.hdr.sgml : 20150504 20150504170157 ACCESSION NUMBER: 0001062993-15-002351 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141202 FILED AS OF DATE: 20150504 DATE AS OF CHANGE: 20150504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Toby CENTRAL INDEX KEY: 0001405128 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 15829293 MAIL ADDRESS: STREET 1: 4092 BOCAIRE BLVD. CITY: BOCA RATON STATE: FL ZIP: 33487 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4/A 2014-12-02 2014-12-04 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405128 Wegman Toby C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Coomon Stock, $0.001 par value 2014-12-02 4 S 0 2950 39.39 D 0 D The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person. /s/ Toby Wegman by Carl A. Valenstein, attorney in fact 2015-05-04